Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company’s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).
eMudhra shares crash another 4%, down 40% in 3 sessions. What’s behind this free fall?
eMudhra will exit its global SSL/TLS certificate business following a security incident involving compromised private keys linked to eight intermediate Certificate Authority certificates. The segment
October 23, 2026